reducing people on team
Biotech

Vistagen lays off 20% of staff to focus on anxiety candidate

The cuts are meant to preserve cash as the biotech proceeds with another trial of fasedienol, following a recent phase 3 fail.
Darren Incorvaia Mar 12, 2026 1:16pm
Magnifying glass amplifying warning sign over falling stock figures

Novo Holdings assets shrink by 3rd as Novo Nordisk shares fall

Mar 12, 2026 7:15am
How physiology powers biotech innovation

How physiology powers biotech innovation

Brought to you by American Physiological Society
hands

Building BLOC: Meet Biopharma Leaders of Color

Mar 12, 2026 10:00am
Graphic of a line of blocks with percentages on them with one block in yellow showing an arrow increasing

Small molecules are ‘resurgent’ in orphan drug R&D: Evaluate

Mar 12, 2026 10:30am
Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background

BridgeBio's muscle weakness data impress ahead of FDA filing

Mar 12, 2026 10:30am
More News

Insulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTD

Mar 12, 2026 1:07pm

Ultragenyx gene therapy lessens ammonia levels in ph. 3

Mar 12, 2026 11:33am

Fierce Biotech Layoff Tracker 2026: Vistagen, Evotec & more

Mar 12, 2026 11:30am

French biotech pens $128M deal for Kezar protein degrader work

Mar 12, 2026 9:00am